The Cephalexin Capsules, cataloged under National Stock Number 6505-01-269-9179, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Teva Pharmaceuticals Usa, Inc.. Government technical data includes 7 specifications, cited from the U.S. Government catalog. The record lists 4 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-269-9179 |
| Primary Part Number | NDC00093-3147-05 |
| Item Name | Cephalexin Capsules |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Teva Pharmaceuticals Usa, Inc. |
| Status | ACTIVE |
| Administration | ORAL |
| Primary Container Type | BOTTLE |
| Protective Storage Feature | CONTROLLED ROOM TEMPERATURE |
| Capsule Primary Container Content Quantity | 500.000 |
| Capsule Type | SOFT |
| Capsule Content Form | POWDER |
| Active Medicament Medicinal Strength | 500.000 MILLIGRAMS CEPHALEXIN ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC67877-0219-05 | Ascend Laboratories Llc Dba Ascend Laboratories Llc (USA) |
| NDC00093-3147-05 PRIMARY | Teva Pharmaceuticals Usa, Inc. (USA) |
| NDC68180-0122-02 | Lupin Pharmaceuticals, Inc (USA) |
| NDC42291-0209-50 PRIMARY | Avkare Llc (USA) |
| Reference | Meaning |
|---|---|
| 6505NCM173356 | 5/1 Secondary reference Defense Medical Standardization Board |
| 1450271 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-269-9179 is a Cephalexin Capsules, manufactured by Teva Pharmaceuticals Usa, Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-269-9179 has 4 manufacturer part numbers on file: NDC67877-0219-05 (Ascend Laboratories Llc Dba Ascend Laboratories Llc), NDC00093-3147-05 (Teva Pharmaceuticals Usa, Inc.), NDC68180-0122-02 (Lupin Pharmaceuticals, Inc), NDC42291-0209-50 (Avkare Llc).
Key specifications for NDC00093-3147-05: Administration: ORAL; Primary Container Type: BOTTLE; Special Features: EACH CAPSULE, FOR ORAL ADMINISTRATION,CONTAINS 500 MILLIGRAMS (MG) OF CEPHALEXIN AS THE ACTIVE INGREDIENT. IN BOTTLES OF 500 CAPSULES. STORE AT 20-25C (68-77 F); (SEE USP CONTROLLED ROOM TEMPERATURE).; Protective Storage Feature: CONTROLLED ROOM TEMPERATURE. 7 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.